Ireland
--:--IST
Recruiting Not applicable

The Effect of a Mandala Coloring-Based Nursing Intervention on Perceived Nursing Image and Anxiety in Children Hospitalized in a Pediatric Clinic: A Randomized Controlled Trial

NCT07845123 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-11-01
Last updated
2026-09-28

Condition(s) studied

Attitude to Health

Investigational drug(s) / intervention(s)

Mandala Coloring

Mandala Coloring: Children in the intervention group will receive a mandala coloring-based nursing intervention conducted by the researcher for 20 minutes once daily over three consecutive days. The session will take place in the patient's room or a quiet area within the pediatric clinic at a time that does not interfere with routine care. Each child will be provided with an individual mandala coloring book and a set of 12 colored pencils. Prior to the session, brief communication will be established to explain the activity, allowing the child full autonomy over color selection and coloring style without interference. Communication from the researcher will remain neutral, standardized, and age-appropriate. Children in the control group will receive routine clinical care only, with no mandala coloring or other distraction interventions applied.

Study summary

The purpose of this study is to evaluate the effect of a mandala coloring-based nursing intervention on perceived nursing image and state anxiety levels in children aged 8-11 years hospitalized in a pediatric clinic.

Eligibility

Sex
ALL
Min age
8 Years
Max age
11 Years
Healthy volunteers
No
Inclusion Criteria: * Aged between 8 and 11 years * Hospitalized in the Pediatric Clinic of Kilis Alaeddin Yavaşça State Hospital * Expected hospitalization for at least three more days based on clinical evaluation and having no clinical impediment to completing the 3-day intervention protocol * Able to read and write in Turkish with adequate cognitive ability to understand questions * Willingness of both child and parent to participate, with written informed consent provided by the parent * Being able to communicate at an adequate level Exclusion Criteria: * Inability to complete the 3-day intervention protocol due to early discharge or other reasons * Deterioration of the child's clinical condition preventing continuation of the application * Inability to complete data collection or outcome measurement procedures * Request by the child or parent to withdraw from the study at any stage

Primary outcome measure(s)

  • Introductory Information Form — Baseline
    The Introductory Information Form was prepared by the researchers based on the relevant literature. The form consists of a total of 10 questions designed to assess the sociodemographic characteristics of the children and their parents, as well as information regarding hospitalization. It includes questions concerning variables such as the child's age, gender, grade level, previous hospitalization experience, duration of stay, and reason for admission, as well as the parent's age, education level, employment status, and family type.
  • State Anxiety Level — Baseline (Day 1), Day 3 (1 hour after the final intervention session), and Pre-discharge (approximately 1 hour before discharge).
    Assessed using the State Anxiety Inventory for Children (SAIC / STAIC). The scale consists of 20 items scored between 20 and 60, where higher scores indicate higher levels of state anxiety.
  • Perceived Nursing Image — Baseline (Day 1) and Pre-discharge (approximately 1 hour before discharge).
    Assessed using the Children's Perceived Nursing Image Scale. The scale consists of 35 items scored between 35 and 175, where higher scores indicate a more positive perception of the nursing image.

Trial sites (1)

FacilityCityRegionStatus
Kilis Prof. Dr. Alaeddin Yavaşca State Hospital, Kilis, Central Kilis Central Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07845123 on ClinicalTrials.gov ↗ ← All trials in Turkey